Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supreme Court To Hear MedImmune Patent Case Against Genentech

This article was originally published in The Pink Sheet Daily

Executive Summary

MedImmune’s suit challenges the validity of the Cabilly patent, which it licenses from Genentech.

You may also be interested in...



Declaratory Judgment Ruling From U.S. Supreme Court Could Impact Licensing Deals, ANDAs

High court is mulling MedImmune's right to challenge a patent licensed from Genentech while continuing to make royalty payments.

Declaratory Judgment Ruling From U.S. Supreme Court Could Impact Licensing Deals, ANDAs

High court is mulling MedImmune's right to challenge a patent licensed from Genentech while continuing to make royalty payments.

MedImmune Plans To Expand Sales Force As It Reacquires Synagis Promotion Rights

Abbott will release co-promotion rights for the respiratory syncytial virus therapy effective June 30, 2006.

Related Content

Topics

UsernamePublicRestriction

Register

PS063735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel